This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
S

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susan Halabi
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susan Halabi
35 views
June 26, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

2024 ASCO® Annual Meeting Insights Hub: GU Videos

20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
09:00
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiratero…

Feat. C. Kyriakopoulos
06:58
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very…

Feat. M. Zarba
View All

Related Content

AUTOPLAY
International Urology Cancer Summit - IUCS

Second International Urology Cancer Summit

Fri, Sep 27, 2024
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
11:56
Ana Aparicio

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

27:04
Fengting Yan

Cancer Screening Molecular Tools

29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
08:05
Total Health

Prostate Cancer Updates From ASCO® 2023

Feat. T. Zhang
11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan
17:33
Insights from AUA 2024 Annual Meeting

AUA 2024 Insights: "Manipulating the Androgen Axis - New Agents…

Feat. D. Jarrard
21:17
Manish Kohli

Time to Castrate Resistance in mCSPC Using Standard of Care Intensif…

19:07
Stanford Medicine

Stanford Medicine Advances in Imaging to Improve Prostate Cancer Dia…

Feat. G. Sonn
09:45
Northwestern Medicine Oncology and Hematology

Differences Between Urologists and Medical Oncologists in the Manage…

Feat. W. Catalona
25:33
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Prostate Cancer Updates From ASCO GU 20…

Feat. J. Berchuck, A. Choudhury
12:39
ASCO GU 2023 Conference Coverage

Efficacy and Safety of Darolutamide in Combination With ADT and Doce…

Feat. C. Sternberg
10:13
Judd Moul

Treatment Intensification in Advanced Prostate Cancer

14:51
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK…

Feat. S. Freedland
10:12
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 Randomized EMBARK Study - Enzaluta…

Feat. S. Freedland
34:43
OncoAlert

Year in Review: Therapeutic Advances in Prostate Cancer

Feat. N. Agarwal